Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.210
+0.020 (0.63%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Niagen Bioscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 130.42 | 129.42 | 99.6 | 83.57 | 72.05 | 67.45 | |
Revenue Growth (YoY) | 20.84% | 29.95% | 19.18% | 15.99% | 6.82% | 13.83% |
Cost of Revenue | 46.58 | 46.23 | 38.01 | 32.79 | 29.25 | 25.96 |
Gross Profit | 83.83 | 83.19 | 61.59 | 50.78 | 42.8 | 41.49 |
Selling, General & Admin | 66.18 | 62.56 | 47.84 | 51.42 | 56.6 | 64.73 |
Research & Development | 6.55 | 6.33 | 6.02 | 4.96 | 4.83 | 3.83 |
Other Operating Expenses | - | 1.98 | - | - | - | - |
Total Operating Expenses | 72.73 | 70.88 | 53.86 | 56.38 | 61.43 | 68.56 |
Operating Income | 11.1 | 12.31 | 7.73 | -5.6 | -18.63 | -27.07 |
Interest Income | - | - | - | - | 2.09 | - |
Other Non-Operating Income (Expense) | 6.83 | 3.83 | 2.26 | 0.66 | 0 | -0.06 |
Total Non-Operating Income (Expense) | 6.83 | 3.83 | 2.26 | 0.66 | 2.09 | -0.06 |
Pretax Income | 17.93 | 16.14 | 9.98 | -4.94 | -16.54 | -27.13 |
Provision for Income Taxes | 1.06 | 0.81 | 0.31 | 0 | - | - |
Net Income | 16.87 | 15.33 | 9.68 | -4.94 | -16.54 | -27.13 |
Net Income to Common | 18.64 | 17.38 | 8.55 | -4.94 | -16.54 | -27.13 |
Net Income Growth | 32.13% | 103.30% | - | - | - | - |
Shares Outstanding (Basic) | 79 | 79 | 76 | 75 | 70 | 67 |
Shares Outstanding (Diluted) | 85 | 85 | 78 | 75 | 70 | 67 |
Shares Change (YoY) | 7.42% | 9.36% | 4.19% | 7.54% | 3.79% | 10.02% |
EPS (Basic) | 0.24 | 0.22 | 0.11 | -0.07 | -0.24 | -0.40 |
EPS (Diluted) | 0.21 | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 |
EPS Growth | 18.45% | 81.82% | - | - | - | - |
Free Cash Flow | 4.11 | 13.21 | 11.95 | 6.97 | -15.43 | -24.57 |
Free Cash Flow Growth | -78.99% | 10.60% | 71.42% | - | - | - |
Free Cash Flow Per Share | 0.05 | 0.15 | 0.15 | 0.09 | -0.22 | -0.37 |
Gross Margin | 64.28% | 64.28% | 61.84% | 60.76% | 59.40% | 61.51% |
Operating Margin | 8.51% | 9.51% | 7.76% | -6.70% | -25.85% | -40.14% |
Profit Margin | 12.93% | 11.84% | 9.72% | -5.91% | -22.96% | -40.22% |
FCF Margin | 3.15% | 10.21% | 11.99% | 8.34% | -21.42% | -36.43% |
EBITDA | 11.98 | 13.1 | 8.54 | -4.57 | -17.57 | -25.96 |
EBITDA Margin | 9.19% | 10.12% | 8.57% | -5.47% | -24.39% | -38.49% |
EBIT | 11.1 | 12.31 | 7.73 | -5.6 | -18.63 | -27.07 |
EBIT Margin | 8.51% | 9.51% | 7.76% | -6.70% | -25.85% | -40.14% |
Effective Tax Rate | 5.91% | 5.02% | 3.05% | 0.00% | 0.00% | 0.00% |